Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure

European Heart Journal

Volumn 26, Issue 4, 2005, Pages 357-362

  Guzzetti, Stefano ^a   La Rovere, Maria Teresa ^b   Pinna, Gian Domenico ^b   Maestri, Roberto ^b   Borroni, Ester ^a   Porta, Alberto ^a   Mortara, Andrea ^c   Malliani, Alberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS   (Italy)

^c Policlinico di Monza   (Italy)

Author keywords

Autonomic nervous system; Heart failure; Heart rate variability; Progressive pump failure; Sudden death

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; ARTICLE; AUTOANALYSIS; AUTONOMIC NERVOUS SYSTEM; BLOOD CHEMISTRY; CAUSE OF DEATH; CLINICAL EXAMINATION; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; FRACTAL ANALYSIS; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE VARIABILITY; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGRESSIVE PUMP FAILURE; SINUS RHYTHM; SPECTROSCOPY; SUDDEN DEATH;

CIRCADIAN RHYTHM; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART RATE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY WEDGE PRESSURE; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 14144253077     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi067     Document Type: Article

References (26)

1. Hjalmarson A, Goldstein S, Fagerberg B et al. for the MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). JAMA 2000;283:1295-1302.
2. Teerlink JR, Jalaluddin M, Anderson S et al. (Prospective Randomized Milrinone Survival Evaluation) Investigators. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 2000;101: 40-46.
3. Nolan J, Batin PA, Andrews R et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 1998;98:1510-1516.
4. Galinier M, Pathak A, Fourcade J et. al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J 2000;21:475-482.
5. La Rovere MT, Pinna GD, Maestri R et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003;107:565-570.
6. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards and measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-1065
7. Furlan R, Guzzetti S, Crivellaro W et al. Continuous 24 hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990;81:537-547.
8. Bernardi L, Valle F, Coco M et al. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovasc Res 1996;32:234-237.
9. Lombardi F, Sandrone G, Mortara A et al. Linear and nonlinear dynamics of heart rate variability after acute myocardial infarction with normal and reduced left ventricular ejection fraction. Am J Cardiol 1996;77:1283-1288
10. Butler GC, Ando S, Floras GS. Fractal component of variability of heart rate and systolic blood pressure in congestive heart failure. Clin Sci 1997;92:543-550.
11. Malliani A, Pagani M, Lombardi F et al. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84:482-492.
12. Guzzetti S, Mezzetti S, Magatelli R et al. Linear and non-linear 24 h heart rate variability in chronic heart failure. Auton Neurosci 2000;86:114-119.
13. Kitney RJ, Rompelman O. The Study of Heart Rate Variability. Oxford, UK; Clarendon Press, 1980.
14. Bonaduce D, Marciano F, Petretta M et al. Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation 1994;90:108-113.
15. Mortara A, Sleight P, Pinna GD et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation 1997;96:246-252.
16. Taylor JA, Carr DL, Myers CW et al. Mechanisms underlying very low frequency RR-interval oscillations in humans. Circulation 1998; 98:547-555.
17. Gustafsson F, Torp-Pedersen C, Brendorp B et al. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J 2003;24:863-870.
18. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
19. Guzzetti S, Cogliati C, Turiel M et al. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J 1995;16:1100-1107.
20. van de Borne P, Montano N, Pagani M et al. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997;95:1449-1454.
21. Mortara A, La Rovere MT, Signorini MG et al. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J 1994;71:422-430.
22. Ponikowski PT, Chua PT, Piepoli M et al. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 1997;96:2586-2594.
23. Malliani A, Montano N. Emerging excitatory role of cardiovascular sympathetic afferents in pathophysological conditions. Hypertension 2002;39:63-68.
24. Reynolds MR, Josephson ME. MADIT II Debate. Risk stratification, costs, and public policy. Circulation 2002;108:1779-1783.
25. Grimm W, Christ M, Bach J, Müller HH et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation 2003;108:2883-2891.
26. Bloomfield DM, Steinman RC, Namerow PB et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy. A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 2004;110:1885-1889.